Introduction
Adenovirus (Ad)-based vectors are now the most commonly used vector in human trials of gene transfer. More dramatically, recent demonstrations confirm the high efficacy and safe use of recombinant Ad (rAd)-based vaccines in infectious and acquired disease applications, including human immunodeficiency virus (HIV)-AIDS, Ebola, toxoplasmosis, H5N1 influenza and cancer. [1] [2] [3] [4] [5] [6] Despite this widespread utility, little information is available regarding the mechanisms as to why rAds can elicit robust adaptive immune responses (both humoral and cellular). Although we, and others, have recently implicated intracellular signaling systems as mediating several important aspects of this response (that is, Ad interactions with the Toll-like receptor (TLR) system), it is also clear that instantaneous interactions of rAds with the extracellular pathogensensing complement system may also be significantly modulating these intracellular responses. [7] [8] [9] [10] [11] [12] The complement system is an ancient defense system that innately recognizes pathogen-associated molecular patterns on a variety of organisms including bacteria, viruses and protozoan parasites. Opsonization of invaders by complement proteins facilitates downstream phagocytosis by platelets, macrophages and/or other cells that have complement receptors, initiates proinflammatory responses that enhance adaptive immune responses and facilitates destruction of some pathogens directly. 13, 14 The classical complement pathway (CP) is initiated when circulating antibody molecules recognize and bind to an invading pathogen. This binding leads to the activation of C1q, which binds the antibodyantigen complex, as well as activates two molecules each of C1r and C1s. The C1qrs complex next recruits C4, which is cleaved by C2 forming the CP-C3 convertase. In contrast, the alternative pathway (AP) of complement activation does not depend on the initial binding of an antibody molecule to a pathogen to initiate pathogen opsonization. Rather, pathogen motifs may result in direct binding and activation of C3, recruitment and activation of Factor B (FB) and covalent attachment of properdin and Factor D, resulting in the formation of the AP-C3 convertase. The CP or AP-C3 convertases facilitate further C3 cleavage, assembly of the C5 convertase and ultimately the membrane attack complex. Activation of the complement system by the CP is amplified by eventual recruitment of the more ancient AP. Some pathogens may activate complement by way of direct interactions with the mannanbinding lectin pathway of complement activation. The mannan-binding lectin pathway depends on the recognition of carbohydrate motifs on bacterial pathogens, and activates the CP by interactions with C4, C2 or natural antibody. 15 It is becoming increasingly evident that the rapid responses initiated by the activation of the complement system have significant impact on 'downstream' adaptive immune responses. 16, 17 Studies in human systems suggest that Ads can activate the human complement system via interactions with either the CP (in the context of preexisting Ad immunity) or AP systems (in the absence of preexisting Ad immunity). 8, 11, 12 Furthermore, we have recently shown that several rapid immune responses, typically noted after systemic Ad vector injections into Ad-naive mice, are also significantly impacted upon by the presence of a fully functional complement system. 12, 18 For example, multiple cytokines and chemokines, noted to rise to significant levels in the plasma of Ad-injected wild-type (WT) mice, do so in a C3-dependent manner in vivo. 12 More dramatically, we have shown that the utilization of rAds both in vitro and in vivo results in a rapid and profound change in the cellular transcriptome, with a high percentage of these genes being rapidly induced (or repressed) by Ads in a C3-dependent manner. 9, 12 With this information in hand, we wished to understand the individual role(s) played by the CP or AP complement pathways relative to Ad-induced innate immune responses and, furthermore, to implicate and identify some of the specific complement proteins participating in these responses in Ad-naive mice. In addition, we aimed to delineate the role of the complement system in the humoral response to both the rAd vector and the transgene it expresses. Such knowledge may not only shed light on why these viruses generate such robust (and potentially very useful) immune responses but also may direct future efforts to further improve the efficacy and/or safety of this important gene transfer platform. We have undertaken this task by using multiple strains of genetically engineered knockout (KO) mice inclusive of C1q-KO and C4-KO mice (deficient in classical pathway and mannan-binding lectin pathways), FB-KO mice (deficient in AP) and the completely complement-deficient C3-KO mouse (deficient in common pathway) to further delineate those aspects of the Ad-induced immune responses that are dependent on the classical pathway, or APs, or those that are common to both. By simultaneously analyzing numerous aspects of the Ad-induced immune response in each of these strains of mice, our results demonstrate that the immune response to Ad vectors is complex and that assigning individual aspects of this response to either arm of the complement pathway is a difficult task. However, we uncover individual roles for members of the AP and CP complement pathways, and also reveal a critical role for the complement C3 protein in Ad vector-induced humoral responses.
Results
Ad-induced thrombocytopenia is dependent on both C3 and FB Twenty-four hours after vector or mock treatment, blood platelet concentrations were quantified for each of the respective strains of mice ( Figure 1 ). When compared with mock-injected controls at the same time point, Adinjected WT mice demonstrated a significant decrease in blood platelets by 24 h.p.i (hours post injection) (Po0.01). Ad-induced thrombocytopenia is dependent on the presence of a functional C3 protein, as platelet numbers did not decrease in C3-KO mice at this rAd dose, a result we had noted in previous studies. 12 The results in Figure 1 also demonstrate that Ad-induced thrombocytopenia does not occur after Ad injections into FB-KO mice. However, significant thrombocytopenia did occur when C4-KO and C1q-KO mice were identically injected (Po0.01). These results provide strong evidence that Ad-induced thrombocytopenia is dependent on the full functionality of the complement system mediated by C3, and that this functionality is further dependent on FB, implicating the need for a fully functional AP of complement in this response.
Ad-induced transcriptome dysregulation is dependent on factors of both the classical and alternative complement pathways
Our previous work has shown that rAd-induced transcriptome changes in the murine liver require C3 and a fully functional complement system. 12 To determine whether factors of the AP and/or CP are required in this response, we completed similar studies in APdeficient FB-KO mice as well as in CP-deficient C4-KO and C1q-KO animals ( Table 1) . We expanded our analysis of C3-dependent, Ad-induced gene inductions Figure 1 Platelet count assessments in recombinant adenovirus (rAd)-injected C57BL/6 and complement-deficient mice. All mice were injected intravenously with 7.5 Â 10 10 viral particle (vp) per mouse. Whole-blood samples were collected at 24 h.p.i., and platelets were enumerated using the Unopette platelet counting system with a hemocytometer. Samples were taken from mock-injected mice and compared with virus-injected animals of the indicated genotype. Bars represent mean ± s.d. **Po0.01 was deemed a statistically significant difference. For C57BL/6 mice, N ¼ 14 and N ¼ 10 for mock and virus-injected mice, respectively. For C3-KO, N ¼ 6 and N ¼ 11; for Factor B knockout (FB-KO), N ¼ 16 and N ¼ 11; for C4-KO, N ¼ 6 and N ¼ 8; for C1q-KO, N ¼ 6 and N ¼ 11; for mock and virus-injected mice, respectively.
Complement factors in innate and humoral immunity to Ad DM Appledorn et al to various members of the TLR signaling pathway (MyD88, TRAF2-bp, TRIM30, CD14 and TLRs 2, 3, 6 and 9), markers of endothelial cell activation (intracellular adhesion molecule (ICAM), vascular cell adhesion molecule (VCAM) and E-selectin), interferon response markers (IRF-7 and OAS1a) and negative regulators of cytokine signaling (SOCS-1 and SOCS-3). The expression of these genes was evaluated in addition to a subset of genes that we have already shown to be dysregulated in response to rAd challenge in a complement-dependent manner. 12 We observed a significant requirement for C3 in the induction of all genes tested (Po0.05) except E-selectin and IRF-7. Surprisingly, in most cases, we were unable to ascribe these same changes to either the AP or CP of the complement pathway. In fact, we observed statistically higher levels of ADAR, IRF-7, OAS1a, TLR2 and TRIM30 gene expressions in Ad-injected FB-KO animals at 6 h.p.i. (Po0.05). We also observed higher levels of CXCL9 and E-selectin in Ad-injected C1q-KO mice (Po0.05). These results parallel our previous work illustrating a similar role for C3 and FB in the innate immune response to alternative human-and simianderived Ad serotypes. 19 However, we observed significantly lower levels of TLR2 expression in rAd-injected C4-KO mice, indicating that functional C4 was required for the full induction of TLR2 expression after rAd injection. A similar response was not observed in rAdinjected C1q-KO mice, indicating that individual proteins within the CP of complement may individually affect Ad-induced, C3-dependent gene activation while not functioning through the canonical classical pathway.
Ad-induced cytokine and chemokine responses at 6 h.p.i. are dependent on C3, but independent of FB, C1q, and C4
We, and others, have previously characterized individual plasma cytokine and chemokine levels in mice that have been exposed to systemic administrations of high-dose rAds. 12, [20] [21] [22] More importantly, several important cytokines and chemokines that are found to be elevated after high-dose rAd injections in mice appear to be elicited to maximal levels only if a functional C3 protein is present. 12 To begin to delineate which of several complement proteins may be important for this complex complement-dependent immune response, we quantified the plasma levels of various cytokines and chemokines known to be induced by intravenous rAd injection in mice deficient in either AP (FB-KO) or CP proteins (C4, C1q) at 6 h.p.i. (Figure 2 ).
After intravenous injection of 7.5 Â 10 10 viral particle (vp) per mouse, blood was isolated at 6 h.p.i., and plasma cytokine and chemokine levels were evaluated using a multiplex bead-based enzyme-linked immunosorbent assay (ELISA) (Figure 2 ). At this time point, we observed that Ad injection into C57BL/6 mice resulted in a significant induction of interleukin (IL)-12(p40), keratinocyte derived chemokine (KC), granulocyte-colony-stimulating factor (G-CSF), monocyte chemotactic protein-1 (MCP-1) and regulated upon activation, normal T-cell expressed, and secreted (RANTES) (Po0.05). Although not significant due to mouse-to-mouse variability in this study, we also observed elevations of IL-6 and macrophage inflammatory protein-1b (MIP-1b), two factors that we have shown to be significantly induced by rAd in previous studies. We found that the induction of many of these factors were dependent on a functional C3 protein. Specifically, in addition to G-CSF, which we have previously shown to be C3-dependent, we found that the induction of plasma IL-12(p40), MCP-1 and RANTES levels were dependent on functional C3 expression (Po0.05). Furthermore, we found that the induction of KC at 6 h.p.i. was also dependent on C3 (Po0.05), a result we have previously shown at 1 h.p.i. 12 There was an indication that the CP may be important in this response as we saw significantly lower levels of KC in rAd-injected C1q-KO mice. However, this result was not observed in Ad-injected C4-KO mice. We did not Complement factors in innate and humoral immunity to Ad DM Appledorn et al detect a significant role for FB, C4 or C1q in the induction of any other cytokine or chemokine studied. We also evaluated the induction of these factors at both 1 and 24 h.p.i. Although we recapitulated results showing C3 dependence of KC and MCP-1 at 1 h.p.i., we did not detect a role for any other complement factor studied at these two additional time points (data not shown). This may indicate that the relative contribution of each of these pathways is below the detection limit of this complex in vivo analysis, or that most Ad-induced, complement-dependent innate immune responses are primarily dependent only on C3. 15 Differential transduction or sequestration of Ads by hepatocytes in these various strains of complementdeficient mice may nonspecifically skew the results obtained in this study. Using a histological approach, we did not observe a difference in X-gal staining in the sections of livers derived from each rAd5-LacZ-injected Figure 1) . Furthermore, we did not note a significant difference in either b-galactosidase activity or Ad genomes within the livers harvested from these same animals (Supplementary Figure 1) . These results exclude potentially artifactual results based on altered viral transduction profiles, and in fact support published evidence indicating that multiple blood factors unrelated to complement dictate liver transduction. [23] [24] [25] [26] rAd-induced IkBa degradation, but not ERK1/2 activation, is dependent on complement C3 protein To further elucidate the central role of C3 in the rapid upregulation of important immune response genes in the liver, and to clarify a mechanism for the heightened C3-dependent cytokine and chemokine responses observed shortly after rAd injection, we evaluated two factors with major roles in innate immune response pathways, the degradation of inhibitor of Kappa light chain gene enhancer in B cells, alpha (IkBa) as an indicator of NF-kB activation (Figure 3a ) and the activation of extracellular signal-regulated kinase (ERK1/2) (Figure 3b ). Because we have identified a role for C3, but not for FB, C4 or C1q, in the induction of rAd gene expression and plasma cytokine and chemokine induction, we focused specifically on C3 for this analysis. After intravenous injection of 1.5 Â 10 11 vp per mouse of rAd, a dose we have previously used to elucidate complement-mediated transcriptome responses, mice were killed at 15-min intervals, and whole-liver protein homogenates were evaluated for the presence of IkBa and p-ERK1/2 using western blotting followed by LI-COR analysis. At 15 min after injection, we detected a rapid degradation of IkBa, indicative of the robust activation of NF-kB. Interestingly, we observed a significant shift in IkBa degradation kinetics in C3-KO mice as compared with identically injected C57BL/6 mice, with IkBa concentrations returning back to basal levels by 45 min after Ad injection as opposed to 60 min in the Ad-injected control mice (Po0.05). This may partially explain the altered cytokine response and the notable gene expression differences found in the liver of C3-deficient animals. In contrast, although there was a slight difference in basal levels of p-ERK1/2 in uninjected animals, we observed a robust and sustained induction of p-ERK1/2 in C3-KO and normal mice.
We, and others, have previously shown that the elimination of Kupffer cells using clodronate laden liposomes results in dramatic decreases in the rAdinduced innate response, and that the activation of ERK1/2, but not NF-kB, is uniquely Kupffer celldependent. 7, 20, 22 It has also been shown that rAd injection results in evidence of Kupffer cell toxicity within 10 min of intravenous injection, followed by complete Kupffer cell depletion by 24 h after Ad injection. 27 For this reason, we evaluated rAd-induced Kupffer cell toxicity via F4/80 staining and fluorescence microscopy in Ad-injected C3-KO, FB-KO and C1q-KO mice at 24 h.p.i. We did not observe a significant role for any of these proteins in mediating rAd-induced Kupffer cell death at the time point tested (data not shown). This result suggests that the lack of rAd induction of thrombocytopenia observed in C3 and FB-KO mice, and the rAd-induced gene dysregulation, acute cytokine and chemokine differences, and altered kinetics of IkBa degradation observed in C3-KO mice are not due to altered interactions of rAds with Kupffer cells.
Functional complement, including factors of both the AP and CP, is required for the generation of rAd and/or transgene-specific humoral responses in vivo
In addition to the rAd-induced acute innate immune response, another major limitation to the use of rAd Figure 3 The role of C3 in recombinant adenovirus (rAd) vectorinduced ERK phosphorylation and IkBa degradation. Wild-type C57BL/6 and C3-KO mice were injected intravenously with rAd5-LacZ (1.5 Â 10 11 viral particles per mouse). Livers were collected at the indicated time points, snap-frozen and lysates extracted as described in the Materials and methods section. (a) IkBa and tubulin; (b) p-ERK1/2, ERK2 were determined by western blot analysis using LI-COR. Quantification was performed by normalizing the p-ERK1/2 levels to total ERK2 and IkBa levels to tubulin to control for loading (N ¼ 3 for all time points). For each analysis, quantification is shown on the top, and a representative blot on the bottom. Bars represent mean ± s.d. A homoscedastic t-test was used to determine statistical differences between levels in C57BL/6 livers compared with levels in C3-KO mouse livers at each indicated time point (*Po0.05).
Complement factors in innate and humoral immunity to Ad DM Appledorn et al vectors in vaccine, or gene therapy platforms in humans, is the humoral adaptive immune response generated upon vector injection into naive individuals, a response that can limit the efficacy of subsequent vector administrations. These responses manifest in production of high titers of anti-rAd antibodies, of neutralizing antibodies (NAbs) and the generation of antibodies specific for the rAd vector-encoded transgene. Complement is known to play a significant role in the shaping of overall humoral immune responses to other pathogens. 16, 17 For these reasons, we sought to evaluate the role of the complete system (using C3-KO mice), as well as both the AP (FB-KO) and CP (C1q-KO) pathways in vivo.
To assess the role of complement in the development of NAb in vivo, we intravenously injected mice with rAd5 expressing green fluorescent protein (GFP), and harvested plasma from the treated animals 30 days post injection (d.p.i.). Interestingly, we observed dramatic differences in Ad-NAb titers in plasma derived from C3-KO mice as compared with plasma derived from identically treated C57BL/6 mice (Po0.05 at both 1:50 and 1:100 dilutions) (Figure 4 ). To ascribe these differences to the AP and/or CP of complement, we also measured NAb titers in plasma harvested from rAd-GFP-injected FB-KO and C1q-KO mice at 30 d.p.i. The high variability of these results prevented us from determining the relative contributions of these factors in the generation of NAbs, although the trend suggests that both the AP and CP may play partial roles in this complement (C3)-dependent response.
On the basis of these results, we hypothesized that the observed decrease in Ad-specific NAbs in C3-KO mice may be a consequence of low titers of anti-rAd-induced IgG. To address this question, we used an ELISA-based assay to measure rAd-specific antibodies in plasma derived from Ad-injected control and experimental mice at 30 d.p.i. (Figure 5a ). At this time point, we found that both C3-KO and FB-KO mice, but not C1q-KO mice, had significantly lower titers of anti-rAd-specific IgG (Po0.01). To further characterize anti-Ad IgG responses, we also assessed the IgG1, IgG2c (IgG2a), IgG2b and IgG3 subclasses of Ad-specific IgG antibodies, all of which were significantly induced by Ad at 30 d.p.i. (Po0.05) (Figure 5b ). We found that both IgG1 and IgG3 rAd-specific antibodies were significantly lower in C3-KO mice as compared with identically injected C57BL/6 control mice (Po0.01). Furthermore, we also found significantly decreased titers of IgG1 and IgG2c antibodies in C1q-KO mice and significantly reduced IgG3 antibodies in FB-KO mice (Po0.05). Surprisingly, we detected significantly higher titers of IgG2c antibodies in C3-KO mice as compared with C57BL/6 mice (Po0.01). The IgG2c/IgG1 ratio is believed to indicate the relative contribution of the Th1/Th2 response. Using this formula, we observed a shift in the Th1/Th2 balance with greater than eightfold higher Th1 response in C3-KO mice as compared with C57BL/6 mice ( Figure 5c ).
We also characterized the humoral response directed against a rAd-encoded transgene, in this case GFP ( Figure 6) . Surprisingly, at 30 d.p.i., we detected significantly higher levels of anti-GFP-specific IgG in rAd-GFP-injected C3-KO mice (Po0.05) (Figure 6a) . However, we did not detect a significant difference in the titer of anti-GFP antibodies in either identically treated FB-KO or C1q-KO mice. We also assessed the titers of the major IgG subclasses (Figure 6b ). Similar to the rAdspecific response, we found a significantly higher titer of GFP-specific IgG2c in C3-KO mice as compared with C57BL/6 mice (Po0.01). In fact, the titer of anti-GFPspecific IgG2c antibodies in plasma from C57BL/6, FB-KO and C1q-KO mice was not significantly different from mock-injected mice. Additionally, we did not detect titers of IgG2b or IgG3 in plasma derived from these mice (data not shown). These data indicate that the major response to a rAd-encoded transgene such as GFP is primarily an IgG1 response (Th2) in C57BL/6 WT mice, whereas a GFP-specific Th1 response, indicated by significantly higher levels of IgG2c, predominates in C57BL/6 mice deficient in a functional complement system (Figure 6c ). It is possible that injection of a GFPexpressing Ad elicits an innate response distinctly different than a rAd5 vector expressing LacZ. To address this possibility, we completed cytokine, chemokine and transcriptome analyses using rAd5-GFP vectors and compared them with rAd5-LacZ-elicited responses in WT C57BL/6 animals. Essentially identical results were observed, eliminating the possibility that the altered adaptive immune responses to a rAd-encoded transgene illustrated here were a result of differing innate responses between the LacZ and GFP vectors (data not shown).
Discussion
Gene transfer technologies continue to hold potential for addressing a number of difficult medical problems, both genetic and acquired. Relative to their use in vaccine development, Ad-based vaccines have recently shown great promise in a number of applications that require elicitation of robust immune responses, such as combined humoral and cellular immune responses. [1] [2] [3] [4] [5] [6] We have recently focused on Ad interactions with the complement system, and how these interactions may shape these important Ad-induced immune responses. Bars represent mean ± s.d. '**' represents a statistical difference, as measured by a homoscedastic t-test, in neutralizing antibody titers found in plasma derived from C57BL/6 animals versus C3-KO animals (Po0.01).
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We, and others, have previously demonstrated that the Ad capsid is opsonized by several complement proteins, even in the absence of preexisting anti-Ad immunity, suggesting that both the classical and alternative arms of the complement system are potentially involved in generating both innate and adaptive immune responses to rAd vectors. 8, 11 In this study, we have attempted to delineate the importance of Ad interactions with specific components of the murine complement system, and to determine which of these interactions might be responsible for specific immune responses typically noted after rAd vector administration. 
Ad-induced thrombocytopenia is a well-known problem noted within days of intravenous administration of large doses of Ad vectors, and is primarily due to a consumptive process. 28 In a previous report, we have confirmed that this response is dependent on the presence of the murine C3 protein, as Ad injections into C3-KO mice do not provoke thrombocytopenia. 12 In this study, we have not only confirmed those findings but also now demonstrate that thrombocytopenia is avoided after Ad injections into FB-KO mice as well, suggesting that the AP of complement activation is primarily responsible for Ad-induced thrombocytopenia. Strengthening this conclusion, we noted that thrombocytopenia was still noted in Ad-injected C4-KO and C1q-KO mice. On the basis of these results, it may be that the initial activation of the AP of complement activation by Ads results in opsonization of Ad by C3 and FB, precipitating downstream events such as enhanced interactions with the blood platelets themselves, and/or macrophages or endothelial cells of the reticuloendothelial system. Our previous studies in human models of Ad complement interactions support this notion. 11 These initial interactions, occurring within minutes of Ad exposure, would be predicted to critically impact on several important 'downstream' immune responses, such as the rapid induction of the liver transcriptome, as well as the induction of important pro-inflammatory chemokines and cytokines from several cellular sources in addition to platelets. 9, 10, 12 In this study, we found that the expression of markers of endothelial cell activation in the liver, including E-selectin, VCAM and ICAM, was significantly induced by intravenous rAd injection, and that this induction was dependent on functional C3 protein. Surprisingly, we were unable to determine the relative roles of the AP or CP in this or other C3-dependent transcriptome responses, except for the induction of TLR2, which is partially mediated by C4. The genes queried included MyD88 and TLR9, which are factors that we, and others, have shown to be involved in the innate response to rAd. 29, 30 However, although we were unable to ascribe the C3-dependent transcriptome inductions elicited by rAd to either the AP or CP, we detected a role for both pathways in modulating gene expression in cells of the liver. For instance, we detected a negative role for both FB and C1q in the regulation of various factors involved in these responses, suggesting that Ad interactions with both the AP and CP arms of the complement system may modulate, rather than synergistically amplify these responses. It is possible that these results are a consequence of altered opsonization of the virus, which, in turn, may affect subtle interactions with various cells of the reticuloendothelial system and/or blood factors involved in rAd vector responses.
We, and others, have characterized both liver-specific and systemic induction of a vast array of cytokines and chemokines after intravenous injection of high titers of rAd vectors. 10, 12, 31, 32 In this study, we show that the induction of the levels of plasma IL-12(p40), MCP-1 and RANTES is dependent on C3 at 6 h.p.i. These are in addition to numerous other factors that we have previously shown to be induced by rAds in a C3-dependent manner. 12 However, we were unable to clarify the role of the AP or CP in mediating these responses. It may be that mouse-to-mouse variability and/or the sensitivity of these assays are such that identifying these differences is not possible. It is also likely that other factors influencing the activation of C3, such as C3-dependent interactions with C5, may play the more important role in these responses, and that, collectively, many redundant pathways underlie the ability of the host complement system to respond to intravenous rAd challenge.
Because we were unable to detect a major role for either the AP or CP in mediating either the C3-dependent transcriptome or cytokine and chemokine responses, we focused on further characterizing the role of C3 in these two important responses. We identified a defect in the kinetics of IkBa degradation subsequent to intravenous rAd administrations into C3-KO mice. As an inhibitor or NF-kB activation, it is likely that the alteration of IkBa degradation directly affects the kinetics of NF-kB activity, and significantly alters subsequent NF-kB-dependent gene expression and/or immune responses. This mechanism may explain the altered gene expression, cytokine and chemokine profiles observed in Ad-injected C3-KO animals as compared with their identically treated WT counterparts. Interestingly, we have recently revealed a similar result in Ad-injected Complement factors in innate and humoral immunity to Ad DM Appledorn et al TLR2-KO mice, and showed that IkBa degradation was completely dependent on MyD88 functionality. 7 The possibility of a direct or indirect interaction between complement and TLR-mediated signaling pathways is intriguing and relatively understudied. 33, 34 Interestingly, we did not detect a role for C3 in rAd-induced ERK1/2 activation. Therefore, the mechanism by which ERK1/2 is activated in the murine liver remains elusive.
The important role that chemokines and cytokines have upon proliferation and activation of T and B cells, neutrophils, as well as NK cells are well known, thus it is possible that interactions with complement proteins such as C3 may be primarily responsible for subsequent rAdinduced antibody responses. 16, [35] [36] [37] We found that functional C3 is required for the induction of rAd NAb, a result that parallels recent findings in the adenoassociated virus (AAV) system. 38 This is a critically important observation, as it may impact the manner in which rAd vectors are administered in a clinical environment. In further analyses of the humoral response elicited by rAd, we revealed deficient rAdspecific IgG responses in C3-KO and FB-KO mice. This may explain decreased NAb titers observed in plasma derived from C3-KO mice. However, this also suggests that although we did not detect acute differences in the innate immune response in AP (FB-KO)-deficient mice, the AP is no less required for maximal induction of antiviral antibody responses. Similarly, we detected a subtle, yet significant, role for the CP in mediating elicitation of maximal Ad-specific IgG1 and IgG2c levels. We also revealed a major deficiency in rAd-specific IgG1 and IgG3 antibody titers in rAd-injected C3-KO mice. In contrast, we observed significantly higher levels of both anti-rAd and anti-GFP IgG2c levels in C3-KO mice. These results demonstrate that Ad interactions with the complement system figure prominently in the skewing of the Th1/Th2 balance. It has been shown, in other systems, that immunizations generating balanced IgG2a/IgG1 ratios correlate with a more protective effect on pathogen challenge. 39 This may partially explain the reduction in NAb antibody titers found in Ad-injected C3-KO mice. It is also known that IgG2a is one of the more potent activators of C3 deposition. The increased levels of IgG2c (C57BL/6 mice lack IgG2a, but encode IgG2c, which functions in a redundant manner) in these mice may indicate a compensation for the lack of C3. It is also likely that interactions between rAd vectors and complement factors alter the rAd, or transgene-specific CTL response, a possibility that remains a focus of important future experiments.
Combining the results of this paper with our previously published studies in rAd-treated C3-KO, TLR2-KO and MyD88-KO mice begin to shed light on the complexities of innate immunity, in the context of Admediated gene transfer specifically, as well as on viralmediated gene transfer in general. 10 The cumulative data strongly suggest that rAd interactions with both complement and TLR systems may be responsible for the known propensity of rAd-based gene transfer to elicit strong humoral immune responses, a benefit when considering using rAds as a vaccine platform. 3 These immune responses are likely consequent to immediate, multifaceted and complement-dependent Ad interactions with platelets, Kupffer cells and/or endothelial cells. Subsequent, intracellular signaling interactions that are mediated by the MyD88 adaptor protein may be modulated by complement opsonized rAds. It will be important to understand these multiple interactions, as this knowledge will foster safer and more efficacious use of Ad-based vectors in a number of diseases, both acquired as well as genetic.
Materials and methods

Mice
Adult C57BL/6 mice and B6.129S4-C3tmlCrr (C3-KO) mice were purchased from Jackson Laboratory (Bar Harbor, ME, USA). FB-deficient mice, on the C57BL/6 background, were a generous gift of Dr Alex Szalai (University of Alabama). C4-KO and C1q-KO mice were a generous gift from Dr Garnett Kelsoe (Duke University Medical Center). When required, mice were anesthetized with a nose cone containing isoflurane. Virus treatment of animals (2-4 months in age) consisted of intravenous injection (via the retro-orbital sinus) of 200 ml of a phosphate-buffered saline solution (PBS, pH 7.4), containing either 7.5 Â 10 10 or 1.5 Â 10 11 total virus particles of either rAd5-LacZ or rAd5-GFP. Plasma and tissue samples were obtained and processed at the indicated times post-injection, using procedures approved by the Michigan State University Institutional Animal Care and Use Committee, and the Duke University Institutional Animal Care and Use Committee.
Ad vector production and characterization
The recombinant adenoviral vectors, rAd5-LacZ and rAd5-GFP, are vectors carrying either CMV-LacZ or CMV-GFP transgene expression cassettes that replace the Ad E1 region of the [E3-]Ad genome, and were grown to high titers on human 293 cells as previously described. 40 Purification consisted of harvesting infected cell lysates, DNase and RNase treatment, and cesium chloride density gradient bandings as per the method of Ng and Graham. 41 The purified vector preparation was extensively dialyzed against 10 mM Tris (pH 8.0), and was stored in 1% sucrose/PBS at À80 1C. The vector preparation was determined to be free of replication competent Ad by PCR using E1-specific primers and titered by SDS disruption and by OD 260 spectrophotometry essentially as previously described. 10, 12 The titer was further evaluated by in vitro transduction of 293 cells and by the enumeration of bacterial b-galactosidase staining cells as previously described, and the viral particle/bacterial b-galactosidase transducing unit titer was approximately 8:1 (data not shown).
42,43
Platelet enumeration
To assess Ad vector-induced thrombocytopenia, platelets were measured at the respective time points by using the Unopette (Fisher Scientific, Waltham, MA, USA) system as previously described. 12 As per manufacturer's recommendations, red blood cells were lysed, and platelets were counted using a Neubauer hemocytometer. Statistically significant differences for Complement factors in innate and humoral immunity to Ad DM Appledorn et al platelet measurements were determined using analysis of variance followed by Tukey's post hoc test.
qRT-PCR analyses
To determine relative levels of a specific RNA transcript, tissues were snap-frozen in liquid nitrogen and RNA was harvested from E100 mg of frozen tissue using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) as per the manufacturer's protocol. Following RNA isolation, reverse transcription was performed on 180 ng of total RNA using SuperScript II (Invitrogen) reverse transcriptase and random hexamers (Applied Biosystems, Foster City, CA, USA) as per the manufacturer's protocol excluding RNaseOUT. Reverse transcription (RT) reactions were diluted to a total volume of 60 ml, and 2 ml was used as the template in the subsequent PCR reactions. Primers were designed using Primer Bank web based-software (http://pga.mgh.harvard.edu/primerbank/). Primers used for amplification have been previously described. 12, 19 Quantitative polymerase chain reaction (qPCR) was carried out on an ABI 7900HT Fast Real-Time PCR System using SYBR Green PCR Mastermix (Applied Biosystems) in a 15 ml reaction. All PCRs were subjected to the following procedure: 95 1C for 10 min followed by 40 cycles of 95 1C for 15 s followed by 60 1C for 1 min. The comparative C t method was used to determine relative gene expression using glyceraldehyde 3-phosphate dehydrogenase (GAPDH) to standardize expression levels across all samples. Relative expression increases were calculated based on levels of a respective transcript quantified in mock-injected animals of the same genotype. Statistical analyses were completed using Student's t-test comparing C57BL/6-treated animals with each respective genotype individually.
Cytokine and chemokine analysis
Utilization of the 23-plex Bio-Rad cytokine assay system (Hercules, CA, USA) was complicated by lot-to-lot variations during the course of our studies. We therefore designed a 7-plex multiplex-based assay system to more accurately determine cytokine/chemokine plasma concentrations as per the manufacturer's instructions (BioRad) by Luminex 100 technology (Luminex, Austin, TX, USA) essentially as previously described. 10 The presence of the following cytokine and chemokines were simultaneously queried in each plasma sample: IL-6, IL-12 (p40), G-CSF, KC, MIP-1b and RANTES. Statistics were completed using Student's t-test.
b-Galactosidase enzyme activity measurement / in situ X-gal staining Sections of snap-frozen liver tissue obtained from killed animals were rapidly embedded in optimal cutting temperature (OCT) fluid, frozen, and, sectioned at a thickness of 7 mm. Tissue sections were in situ stained for bacterial b-galactosidase (LacZ) expression using X-gal substrate, as previously described. 43 To quantitatively assess LacZ activity, snap-frozen samples were homogenized, and LacZ activity was quantified using a bgalactosidase activity detection kit (Stratagene, La Jolla, CA, USA) as previously described. 44 Statistics were completed using analysis of variance followed by Tukey's post hoc test.
Ad genome copy number per diploid genome
To assess the number of Ad genome copies per cell, tissues were snap-frozen in liquid nitrogen and then crushed to a fine powder using a mortar and pestle. DNA was extracted from frozen mouse tissue as previously described. 45 Copy numbers were assessed using real-time PCR-based quantification. Cycling conditions were the same for quantitative real-time polymerase chain reaction (qRT-PCR) analyses. Standard curves were run in duplicate and consisted of six halflog dilutions using total genomic DNA, or DNA extracted from the purified viruses of each respective Ad serotype being tested. These standard curves were used to determine the number of viral genomes present per cell from each tissue sample. Melting curve analysis confirmed the quality and specificity of the PCR (data not shown).
Kupffer cell staining
The evaluation of Kupffer cells in 7 mm liver sections was completed using an F4/80-specific antibody as previously described. 19 
Western blotting
Liver tissue was homogenized in lysis buffer (20 mM Tris-HCl, pH 7.4, 1 mM EDTA and 150 mM NaCl) containing 1% Triton X-100 with protease inhibitors. Homogenized liver tissue was then centrifuged at maximum speed (13 000 g) for 10 min at 4 1C, and the protein concentration of the supernatant was determined using the Bradford method. Western blotting for p-ERK1/2, ERK2, IkBa and tubulin was performed as previously described. 46, 47 Briefly, equivalent concentrations of protein samples were run on polyacrylamide gels and transferred onto nitrocellulose membranes. Blots were then probed with antibodies as described previously using fluorescent secondary antibodies. p-ERK1/2 and IkBa were from Cell Signaling Inc. (Danvers, MA, USA). ERK2 antibody was from Santa Cruz Technology (Santa Cruz, CA, USA) and antibody against tubulin was from Sigma-Aldrich (St Louis, MO, USA). Blots were scanned and bands were quantified using a LI-COR scanner. 47 For data analysis, p-ERK1/2 bands were normalized to ERK2 and IkBa was normalized to tubulin before quantification. Statistics were completed using Student's t-test at each individual time point.
NAb assay
A total of 2 Â 10 3 HEK293 cells were seeded in microwells in 125 ml of complete media (DMEM (Dulbecco's modified Eagle's medium), 10% fetal bovine serum and penicillin/streptomycin/fungizone (PSF). Cells were cultured overnight in a 37 1C, 5% CO 2 incubator. Plasma was heat inactivated for 60 min at 56 1C and brought to room temperature. Dilutions were made as indicated in complete media in a total volume of 100 ml for each well. A total of 1.3 Â 10 6 viral particles (B650 vp per cell) was next added to each dilution and incubated at room temperature for 1 h. A volume of 100 ml of the medium/ plasma/virus mixture was applied to cells and incubated for 4 days. Control samples were incubated with either virus alone or complete media alone. CELLTITER 96 AQ ueous One solution (Promega, Madison, WI, USA) was 
Antibody titering assay
ELISA-based titering experiments were essentially completed as previously described. 48 Briefly, 5 Â 10 8 vp per well or 0.2 mg rGFP protein per well (each diluted in PBS) was used to coat wells of a 96-well plate overnight at 4 1C. Plates were washed with PBS-Tween (0.05%) solution, and blocking buffer (3% bovine serum albumin in PBS) was added to each well and incubated for 1 h at room temperature. For titering of total IgG antibodies, plasma was diluted in 1:800 in blocking buffer, added to the wells and incubated at room temperature for 1 h. Wells were washed using PBS-Tween (0.05%) and HRP (horseradish peroxidase)-conjugated rabbit anti-mouse antibody (Bio-Rad) was added at a 1:4000 dilution in PBS-Tween. Tetramethylbenzidine (TMB) (Sigma-Aldrich) substrate was added to each well, and the reaction was stopped with 1 N phosphoric acid. Plates were read at 450 nm in a microplate spectrophotometer. Subisotype titering was completed with a hybridoma subisotyping kit (Calbiochem, La Jolla, CA, USA) using plasma at a dilution of 1:400. Statistical analyses were completed using Student's t-test comparing values obtained from C57BL/6-immunized mice with immunized mice of each respective genotype.
